Evidence map›Paper›PMID 40366608›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Trends in the incidence of brain cancer and the use of mobile phones: analysis of the Spanish Network of Cancer Registries (REDECAN).

Jaume Galceran, Alberto Ameijide, Adela Cañete, Rafael Peris-Bonet, Arantza López de Munain, Amaia Aizpurúa, Marta de la Cruz, Arantza Sanvisens, María José Sánchez, Isabel Palacios and 10 more

Abstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jaume GalceranTarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Sant Joan de Reus University Hospital, Reus, Tarragona, Spain. jaume.galceran@salutsantjoan.cat.ORCID http://orcid.org/0000-0002-1584-7293
Alberto AmeijideTarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Sant Joan de Reus University Hospital, Reus, Tarragona, Spain.ORCID http://orcid.org/0000-0002-9285-2627
Adela CañetePaediatric Oncohematology Unit, Hospital La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0002-5669-5097
Rafael Peris-BonetPaediatric Oncohematology Unit, Hospital La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0002-4200-2309
Arantza López de MunainBasque Country Cancer Registry , Department of Health, Basque Government, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0001-6820-9124
Amaia AizpurúaBasque Country Cancer Registry , Department of Health, Basque Government, Vitoria-Gasteiz, Spain.ORCID http://orcid.org/0000-0001-9793-7913
Marta de la CruzBasque Country Cancer Registry , Department of Health, Basque Government, Vitoria-Gasteiz, Spain.
Arantza SanvisensEpidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Girona, Spain.ORCID http://orcid.org/0000-0001-6269-5491
María José SánchezGranada Cancer Registry, Andalusian School of Public Health (EASP), Granada, Spain.ORCID http://orcid.org/0000-0003-4817-0757
Isabel PalaciosLa Rioja Cancer Registry, Epidemiology and Health Prevention Service , Logroño, Spain.ORCID http://orcid.org/0009-0003-8786-197X
Paula FranchMallorca Cancer Registry, Public Health and Participation Department, Palma, Spain.
Antonia SánchezMurcia Cancer Registry , Department of Epidemiology, Regional Health Authority, Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, Murcia University, Murcia, Spain.ORCID http://orcid.org/0009-0004-8600-5052
Marcela GuevaraNavarra Cancer Registry, Navarra Public Health Institute, Pamplona, Spain.ORCID http://orcid.org/0000-0001-9242-6364
Marià CarullaTarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Sant Joan de Reus University Hospital, Reus, Tarragona, Spain.ORCID http://orcid.org/0000-0001-8562-117X
Pilar GutiérrezCastilla y León Cancer Registry, Public Health Directorate, Castilla y León Government, Valladolid, Spain.ORCID http://orcid.org/0000-0002-6997-8846
Isabel SáezRegistry of Childhood and Adolescent Tumours of the Valencian Community, Generalitat Valenciana, Valencia, Spain.ORCID http://orcid.org/0009-0002-0401-5034
Marta RodríguezAsturias Cancer Registry, Public Health Directorate, Asturias, Spain.
Araceli AlemánCanary Islands Cancer Registry, Public Health Directorate, Canary Islands Government, Tenerife, Spain.
Consol SabaterCastellón Cancer Registry, Directorate General of Public Health and Addictions, Valencian Government, Castellón, Spain.ORCID http://orcid.org/0000-0002-1211-4764
Spanish Network of Cancer Registries (REDECAN)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe association between the use of mobile phones use and the risk of brain cancer remains controversial. The aim of this study is to describe trends in the incidence of central nervous system (CNS) cancers in Spain and its possible relationship with mobile phone use.

methodsTrends and trend changes from 1985 to 2015 in adjusted incidence rates of CNS cancers by sex, age (adults and children), site, and histological type were assessed using data from 14 general and paediatric cancer registries.

resultsThe study included 20,325 CNS malignancies in adults and 2,372 in children. For adults, the overall rate of malignant brain tumours showed a slight increase of 0.2% (95% CI: 0.1 - 0.4) per year. This increase was concentrated in the early years up to 1996 (1.7% per year, 95% CI: 0.9 - 2.6) followed by 20 years of a non-significant slight decline of -0.1% (95% CI: -0.4 - 0.1) per year until 2015. In children, an increase of 7.6% (95% CI: 2.4 - 13.1) per year until 1991 followed by a decrease of -1.0% (95%CI: -1.7 - -0.3) per year until 2015 was observed. This increase in the incidence in 1980s and early 1990s could be explained by diagnostic improvements especially in imaging techniques implemented during these years.

conclusionThe present findings do not support a possible relationship between the use of mobile phones and the incidence of malignant brain tumours. However, the possibility of the presence of a weak correlation or that a longer latency period would be needed to observe a possible ecological correlation cannot be discarded.

Indexed as

Brain NeoplasmsCell PhoneCell Phone UseAdolescentAdultAgedChildChild, PreschoolFemaleHumansIncidenceInfantMaleMiddle AgedRegistriesSpainBrain tumoursCancer registryIncidence trendsMobile phonesRadiofrequency radiation

Identifiers

PMID40366608
PMCPMC12559055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.